InvAscent

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$13M
Portfolio companies 10
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.09
Exits 2
Key employees Soon
Stages of investment
Private Equity

Areas of investment

  • Health Care
  • Manufacturing
  • Pharmaceutical
  • Biotechnology
  • Health Insurance

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of InvAscent:
Typical Co-investors
InvAscent is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after InvAscent:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Mauritius
Funds with similar focus located in Mauritius:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anova Capital Beijing, Beijing, China
Arlington Capital Partners Chevy Chase, Maryland, United States
Coefficient Ventures California, San Francisco, United States
Culture Convenience Club (CCC) Japan, Tokyo
Emerson Louisiana, Missouri, United States
EOS Syndicate Management -
Fission Capital China, Hong Kong, Hong Kong Island
H20 Capital -
Hear Music Beverly Hills, California, United States
Incubic Venture Fund California, Menlo Park, United States
Mount Kellett Capital Management New York, New York, United States
New Orleans Startup Fund Louisiana, New Orleans, United States
Rowad -
Secure Octane California, San Francisco, United States
SGPA France, Ile-de-France, Neuilly-sur-seine
Shihaisong Capital -
Temasek Holdings Central Region, Singapore, Singapore
Z Nation Lab India, Maharashtra, Mumbai
Zhejiang Meilin Venture Capital China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Malladi Drugs

Biotechnology
Manufacturing
Pharmaceutical
$32M25 Apr 2022 Carlstadt, New Jersey, United States

MediBuddy

Health Care
Health Insurance
Medical
mHealth
$40M02 Feb 2021 Bengaluru, Karnataka, India

Murli Krishna Pharma

Medical
Pharmaceutical
$9M16 Jun 2020 Pune, Maharashtra, India

Sharp Sight

Eyewear
Health Care
Hospital
$9M08 Jun 2020 New Delhi, Delhi, India

Intron Life Sciences

Biotechnology
Health Care
Manufacturing
$10M01 Jan 2019 Hyderabad, Andhra Pradesh, India

Strides Pharma Science

Biotechnology
Health Care
Life Science
Manufacturing
Pharmaceutical
$20M31 Oct 2018 Bengaluru, Karnataka, India

Oliva Clinic

Health Care
Health Insurance
Home Health Care
$832K15 Mar 2017 India, Andhra Pradesh, India

Stericon Pharma

Health Care
Manufacturing
Pharmaceutical
$6M01 Dec 2016 Bengaluru, Karnataka, India

Sandor

Biotechnology
Marketing
Medical Device
$9M08 Jan 2016 Hyderabad, Andhra Pradesh, India

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent InvAscent?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: